With the planned purchase, Boston Scientific will gain several thrombectomy devices to remove clots from blood vessels.
The acquisition is the first major healthcare deal of 2026, a year analysts and industry insiders expect will bring a wave ...
Boston Scientific has agreed to acquire Penumbra in a deal worth about $14.5 billion. Boston Scientific has agreed to acquire ...
Zacks Investment Research on MSN
HOLX vs. SYK: Which medical device leader is a solid bet now?
The global medical device industry is characterized by rapid technological advances, innovations and scientific discoveries.
Boston Scientific’s $374/share Penumbra deal boosts mechanical thrombectomy exposure and growth. Click here to learn more ...
We independently review everything we recommend. When you buy through our links, we may earn a commission. Learn more› By Rory Evans Rory Evans is a writer focused on skin-care and beauty products.
Even after my tests were done, I decided to upgrade certain smart home devices to full-time help. Here's what won out. For more than 10 years Tyler has used his experience in smart home tech to craft ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback